Business


Nestlé Takes Expanded Materna Supplements Range To China

 
• By 

China will be the first market to see the introduction of Nestlé's expanded pregnancy supplement line, Materna.

Opella Study Finds ‘Significant Variation’ In Probiotic Quality In India

 
• By 

Only Opella’s own Enterogermina brand was found by a company-funded study to be contamination-free, to contain the claimed content, and show resistance to all tested antibiotics.

Vision Healthcare Grows VMS Offering With Sweden’s BioSalma

 
• By 

Vision Healthcare adds an established supplements portfolio, alongside a robust omni-channel set-up across the Nordics, with the acquisition of BioSalma.

Three-Quarters Of Global Population Not Getting Enough Omega-3

 
• By 

Research from UK retailer Holland & Barrett, the University of East Anglia and the University of Southampton points to need for Omega-3 supplementation for many consumers.

Innovation & IP


Nestlé Takes Expanded Materna Supplements Range To China

 
• By 

China will be the first market to see the introduction of Nestlé's expanded pregnancy supplement line, Materna.

OTC Firms Must Strike Delicate Balance Between Trust And Personalization

 
• By 

“In the coming years, growth will depend on whether brands can combine trust, personalization, and proof of evidence into one coherent prevention experience,” argue Simon Kucher's Clemens Oberhammer and Christian Rebholz in this exclusive interview.

Valbiotis Sets Up China JV To Take Plant Supplements To Asia

 
• By 

France's Valbiotis has joined forces with China-based Aika to roll out its plant-based dietary supplements in selected Asian markets.

New Magnesium Source For Use In Supplements Approved In EU

 
• By 

The European Commission has added magnesium L-threonate to the list of vitamin and mineral substances which may be used in the manufacture of dietary supplements.

Policy & Regulation


Can US FDA Balance Inspection Generalists And ‘Simple Reform’ With Need For Expertise?

 
• By 

Former agency officials now representing industry worry that a deregulatory bent could be driving "Simple Reform" plan to merge all medical product and clinical research inspectorates and that specialist expertise gained in 2017 "Program Alignment" initiative will be reversed.

Opella Study Finds ‘Significant Variation’ In Probiotic Quality In India

 
• By 

Only Opella’s own Enterogermina brand was found by a company-funded study to be contamination-free, to contain the claimed content, and show resistance to all tested antibiotics.

Third-Party Audit Results ‘Definitely The Direction’ For FDA Supplement Facility Inspection Planning

 

“There's a lot of third-party audit information out there. Could we take that and apply it into our inspectional planning process?” says Office of Dietary Supplement Programs Director Cara Welch.

US FDA Makes Enforcement Discretion Official For Accepted Supplement Label Disclaimer Practice

 

“We have rarely, if ever, enforced this requirement” FDA says announcing enforcement discretion regarding requirement for disclaimer about supplement structure/function and other label claims to be printed on every panel of a product’s package.